Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee, 3427-3428 [2023-00916]

Download as PDF Federal Register / Vol. 88, No. 12 / Thursday, January 19, 2023 / Notices Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; NIEHS Research Intensive Short Courses and Educational Opportunities. Date: April 6, 2023. Time: 1:00 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Beverly W. Duncan, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, (240) 353–6598, beverly.duncan@ nih.gov. Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; NIEHS Genetic Diversity in Toxicity Testing: New Approaches in Determining Response Variability From Environmental Exposures. Date: April 11, 2023. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Environmental Health Sciences, Keystone Building, 530 Davis Drive, Durham, NC 27709 (Virtual Meeting). Contact Person: Leroy Worth, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Science, Research Triangle Park, NC 27709, (984) 287–3340, worth@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: January 12, 2023. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–00920 Filed 1–18–23; 8:45 am] BILLING CODE 4140–01–P khammond on DSKJM1Z7X2PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee Substance Abuse and Mental Health Services Administration, AGENCY: VerDate Sep<11>2014 17:49 Jan 18, 2023 Jkt 259001 Department of Health and Human Services. ACTION: Notice. The Secretary of Health and Human Services announces a meeting of the Interdepartmental Serious Mental Illness Coordinating Committee (ISMICC). The meeting will provide information on federal efforts related to serious mental illness (SMI) and serious emotional disturbance (SED). DATES: March 14, 2023, 11 a.m. to 4 p.m. (EDT)/Open. ADDRESSES: The meeting is open to the public and can be accessed virtually only by accessing: https:// www.zoomgov.com/j/ 1610294627?pwd=V1FTTEtKRmx ORktqNndHMDZhelhxUT09, or by dialing 646–828–7666, webinar ID: 161 029 4627, passcode: 127155. Agenda with call-in information will be posted on the SAMHSA website prior to the meeting at https://www.samhsa.gov/ about-us/advisory-councils/meetings. FOR FURTHER INFORMATION CONTACT: Pamela Foote, ISMICC Designated Federal Officer, SAMHSA, 5600 Fishers Lane, 14E53C, Rockville, MD 20857; telephone: 240–276–1279; email: pamela.foote@samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background and Authority The ISMICC was established on March 15, 2017, in accordance with section 6031 of the 21st Century Cures Act, and the Federal Advisory Committee Act, 5 U.S.C. App., as amended, to report to the Secretary, Congress, and any other relevant federal department or agency on advances in SMI and SED, research related to the prevention of, diagnosis of, intervention in, and treatment and recovery of SMIs, SEDs, and advances in access to services and supports for adults with SMI or children with SED. In addition, the ISMICC will evaluate the effect federal programs related to SMI and SED have on public health, including public health outcomes such as: (A) rates of suicide, suicide attempts, incidence and prevalence of SMIs, SEDs, and substance use disorders, overdose, overdose deaths, emergency hospitalizations, emergency room boarding, preventable emergency room visits, interaction with the criminal justice system, homelessness, and unemployment; (B) increased rates of employment and enrollment in educational and vocational programs; (C) quality of mental and substance use disorders treatment services; or (D) any other criteria determined by the PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 3427 Secretary. Finally, the ISMICC will make specific recommendations for actions that agencies can take to better coordinate the administration of mental health services for adults with SMI or children with SED. Not later than one (1) year after the date of enactment of the 21st Century Cures Act, and five (5) years after such date of enactment, the ISMICC shall submit a report to Congress and any other relevant federal department or agency. II. Membership This ISMICC consists of federal members listed below or their designees, and non-federal public members. Federal Membership: Members include, The Secretary of Health and Human Services; The Assistant Secretary for Mental Health and Substance Use; The Attorney General; The Secretary of the Department of Veterans Affairs; The Secretary of the Department of Defense; The Secretary of the Department of Housing and Urban Development; The Secretary of the Department of Education; The Secretary of the Department of Labor; The Administrator of the Centers for Medicare and Medicaid Services; the Administrator of the Administration for Community Living, and The Commissioner of the Social Security Administration. Non-federal Membership: Members include, not less than 14 non-federal public members appointed by the Secretary, representing psychologists, psychiatrists, social workers, peer support specialists, and other providers, patients, family of patients, law enforcement, the judiciary, and leading research, advocacy, or service organizations. The ISMICC is required to meet at least twice per year. To attend virtually, submit written or brief oral comments, or request special accommodation for persons with disabilities, contact Pamela Foote. Individuals can also register at https:// snacregister.samhsa.gov/. The public comment section will be scheduled at the conclusion of the meeting. Individuals interested in submitting a comment, must notify Pamela Foote on or before February 21, 2023, via email to: Pamela.Foote@ samhsa.hhs.gov. Up to three minutes will be allotted for each approved public comment as time permits. Written comments received in advance of the meeting will be considered for inclusion in the official record of the meeting. Substantive meeting information and a roster of Committee members is E:\FR\FM\19JAN1.SGM 19JAN1 3428 Federal Register / Vol. 88, No. 12 / Thursday, January 19, 2023 / Notices available at the Committee’s website: https://www.samhsa.gov/about-us/ advisory-councils/ismicc. Dated: January 12, 2023. Carlos Castillo, Committee Management Officer. [FR Doc. 2023–00916 Filed 1–18–23; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration khammond on DSKJM1Z7X2PROD with NOTICES Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given that the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention’s (CSAP) Drug Testing Advisory Board (DTAB) will convene via web conference on March 7, 2023, from 10 a.m. EST to 4:30 p.m. EST. The board will meet in open-session March 7, 2023, from 10 a.m. EST to 2 p.m. EST to discuss the Mandatory Guidelines for Federal Workplace Drug Testing Programs, updates to the Electronic Chain of Custody Form (ECCF), as well as updates from the Department of Transportation, the Nuclear Regulatory Commission, the Department of Defense, and the Food and Drug Administration as well as a presentation by Dr. Svante Vikingsson on Fentanyl and Opioids Pulse Study results. The board will meet in closed session on March 7, 2023, from 2:15 p.m. EST to 4:30 p.m. EST to discuss issues surrounding cannabinoids pertaining to the effect of the proliferation of various cannabinoid isomers, including Delta– 8–THC, on federal workplace drug testing programs, including federal and state responses to cannabinoid drug testing issues of concern, and potential SAMSHA actions. In closed session the board will also review information and proposed actions concerning the Department of Health and Humans Services (HHS) Mandatory Guideline internal review and approval process that has not been made public by HHS. Therefore, the March 7, 2023, meeting from 2:15 p.m. to 4:30 p.m. is closed to the public, as determined by the Assistant Secretary for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(9)(B) and 5 U.S.C. App. 2, section 10(d). Meeting registration information can be completed at https:// snacregister.samhsa.gov/. Web conference and call information will be VerDate Sep<11>2014 17:49 Jan 18, 2023 Jkt 259001 sent after completing registration. Meeting information and a roster of DTAB members may be obtained by accessing the SAMHSA Advisory Committees website, https:// www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the Designated Federal Officer, Lisa Davis. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention, Drug Testing Advisory Board. Dates/Time/Type: March 7, 2023, from 10 a.m. EST to 2 p.m. EST: OPEN; March 7, 2023, from 2:15 p.m. EST to 4:30 p.m. EST: CLOSED. Place: Substance Abuse and Mental Health Services Administration, 5600 Fishers Lane, Rockville, MD 20857. Contact: Lisa S. Davis, M.S., Social Science Analyst, Center for Substance Abuse Prevention, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone: (240) 276–1440, Email: Lisa.Davis@ samhsa.hhs.gov. Anastasia Marie Donovan, Public Health Advisor, Division of Workplace Programs. [FR Doc. 2023–00911 Filed 1–18–23; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [FWS–R1–ES–2022–0169; ES11140100000– 234–FF01E0000] Candidate Conservation Agreement With Assurances for the Fisher in Oregon; Enhancement of Survival Permit Applications; Hampton and Starker Site Plans Fish and Wildlife Service, Interior. ACTION: Notice of availability; request for comments. AGENCY: We, the U.S. Fish and Wildlife Service (Service), received two enhancement of survival permit (permit) applications pursuant to the Endangered Species Act (ESA). If granted, the requested permits would authorize take of the fisher (Pekania pennanti), incidental to otherwise lawful activities, if the species becomes federally listed under the ESA. These applications are associated with a template candidate conservation agreement with assurances (CCAA) developed by the Service for the conservation of the fisher. We have also prepared draft environmental action statements documenting our preliminary determination that the permit decisions may be eligible for SUMMARY: PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 categorical exclusion under the National Environmental Policy Act. We provide this notice to open a public comment period and invite comments from all interested parties. DATES: Submit written comments no later than February 21, 2023. ADDRESSES: Obtaining Documents: The applications, application supporting materials, and any comments and other materials that we receive will be available for public inspection at https://www.regulations.gov in Docket No. FWS–R1–ES–2022–0169. Submitting Comments: To submit written comments, please use one of the following methods: • Internet: https:// www.regulations.gov. Search for and submit comments on Docket No. FWS– R1–2022–0169. • U.S. Mail: Attn: Docket No. FWS– R1–ES–2022–0169; U.S. Fish and Wildlife Service Headquarters, MS: PRB/3W; 5275 Leesburg Pike, Falls Church, VA 22041–3803. For more information, see Public Availability of Comments under SUPPLEMENTARY INFORMATION. FOR FURTHER INFORMATION CONTACT: Frank Weaver, via telephone at 541– 957–3471, or via email at Frank_ Weaver@fws.gov. Individuals in the United States who are deaf, deafblind, hard of hearing, or have a speech disability may dial 711 (TTY, TDD, or TeleBraille) to access telecommunications relay services. Individuals outside the United States should use the relay services offered within their country to make international calls to the point-ofcontact in the United States. SUPPLEMENTARY INFORMATION: We, the U.S. Fish and Wildlife Service (Service), have received two enhancement of survival permit (permit) applications pursuant to section 10(a)1(A) of the Endangered Species Act of 1973, as amended (ESA; 16 U.S.C. 1531 et seq.). The two applicants are Hampton Lumber (Hampton) and Starker Forest Inc./Starker Properties LLC (Starker). If granted, either or both of the requested permits would authorize take of the fisher (Pekania pennanti) incidental to the applicants’ routine forest-related management activities, if the species becomes federally listed under the ESA. Each application includes a proposed individual site plan developed under a template candidate conservation agreement with assurances (CCAA) developed by the Service in 2018 for the conservation of the fisher. The conservation measures in the CCAA are intended to provide a net E:\FR\FM\19JAN1.SGM 19JAN1

Agencies

[Federal Register Volume 88, Number 12 (Thursday, January 19, 2023)]
[Notices]
[Pages 3427-3428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00916]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Notice of Meeting for the Interdepartmental Serious Mental 
Illness Coordinating Committee

AGENCY: Substance Abuse and Mental Health Services Administration, 
Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Secretary of Health and Human Services announces a meeting 
of the Interdepartmental Serious Mental Illness Coordinating Committee 
(ISMICC).
    The meeting will provide information on federal efforts related to 
serious mental illness (SMI) and serious emotional disturbance (SED).

DATES: March 14, 2023, 11 a.m. to 4 p.m. (EDT)/Open.

ADDRESSES: The meeting is open to the public and can be accessed 
virtually only by accessing: https://www.zoomgov.com/j/1610294627?pwd=V1FTTEtKRmxORktqNndHMDZhelhxUT09, or by dialing 646-828-
7666, webinar ID: 161 029 4627, passcode: 127155. Agenda with call-in 
information will be posted on the SAMHSA website prior to the meeting 
at https://www.samhsa.gov/about-us/advisory-councils/meetings.

FOR FURTHER INFORMATION CONTACT: Pamela Foote, ISMICC Designated 
Federal Officer, SAMHSA, 5600 Fishers Lane, 14E53C, Rockville, MD 
20857; telephone: 240-276-1279; email: [email protected].

SUPPLEMENTARY INFORMATION: 

I. Background and Authority

    The ISMICC was established on March 15, 2017, in accordance with 
section 6031 of the 21st Century Cures Act, and the Federal Advisory 
Committee Act, 5 U.S.C. App., as amended, to report to the Secretary, 
Congress, and any other relevant federal department or agency on 
advances in SMI and SED, research related to the prevention of, 
diagnosis of, intervention in, and treatment and recovery of SMIs, 
SEDs, and advances in access to services and supports for adults with 
SMI or children with SED. In addition, the ISMICC will evaluate the 
effect federal programs related to SMI and SED have on public health, 
including public health outcomes such as: (A) rates of suicide, suicide 
attempts, incidence and prevalence of SMIs, SEDs, and substance use 
disorders, overdose, overdose deaths, emergency hospitalizations, 
emergency room boarding, preventable emergency room visits, interaction 
with the criminal justice system, homelessness, and unemployment; (B) 
increased rates of employment and enrollment in educational and 
vocational programs; (C) quality of mental and substance use disorders 
treatment services; or (D) any other criteria determined by the 
Secretary. Finally, the ISMICC will make specific recommendations for 
actions that agencies can take to better coordinate the administration 
of mental health services for adults with SMI or children with SED. Not 
later than one (1) year after the date of enactment of the 21st Century 
Cures Act, and five (5) years after such date of enactment, the ISMICC 
shall submit a report to Congress and any other relevant federal 
department or agency.

II. Membership

    This ISMICC consists of federal members listed below or their 
designees, and non-federal public members.
    Federal Membership: Members include, The Secretary of Health and 
Human Services; The Assistant Secretary for Mental Health and Substance 
Use; The Attorney General; The Secretary of the Department of Veterans 
Affairs; The Secretary of the Department of Defense; The Secretary of 
the Department of Housing and Urban Development; The Secretary of the 
Department of Education; The Secretary of the Department of Labor; The 
Administrator of the Centers for Medicare and Medicaid Services; the 
Administrator of the Administration for Community Living, and The 
Commissioner of the Social Security Administration.
    Non-federal Membership: Members include, not less than 14 non-
federal public members appointed by the Secretary, representing 
psychologists, psychiatrists, social workers, peer support specialists, 
and other providers, patients, family of patients, law enforcement, the 
judiciary, and leading research, advocacy, or service organizations.
    The ISMICC is required to meet at least twice per year.
    To attend virtually, submit written or brief oral comments, or 
request special accommodation for persons with disabilities, contact 
Pamela Foote. Individuals can also register at https://snacregister.samhsa.gov/.
    The public comment section will be scheduled at the conclusion of 
the meeting. Individuals interested in submitting a comment, must 
notify Pamela Foote on or before February 21, 2023, via email to: 
[email protected]
    Up to three minutes will be allotted for each approved public 
comment as time permits. Written comments received in advance of the 
meeting will be considered for inclusion in the official record of the 
meeting.
    Substantive meeting information and a roster of Committee members 
is

[[Page 3428]]

available at the Committee's website: https://www.samhsa.gov/about-us/advisory-councils/ismicc.

    Dated: January 12, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023-00916 Filed 1-18-23; 8:45 am]
BILLING CODE 4162-20-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.